The maternal mortality rate in the United States and Uruguay are nearly identical, contradicting the assumption that wealthy developed nations automatically deliver better maternal health outcomes. As of 2024, the U.S. maternal mortality rate stands at 17.9 deaths per 100,000 live births—the most recent data available from the CDC released in March 2026. Uruguay’s most recent available rate, from 2020, was 18.6 deaths per 100,000 live births.
This means the two countries are operating on nearly the same plane when it comes to maternal mortality, with Uruguay’s rate actually slightly lower despite having a significantly smaller population and economy. The comparison matters because it exposes a uncomfortable truth: the United States, with vastly greater healthcare resources and spending, has not translated that investment into maternal mortality outcomes that exceed a Latin American country. The 649 documented maternal deaths in the U.S. in 2024 represent real families, preventable tragedies, and systemic failures that demand examination. Uruguay’s achievement of near-parity, combined with a documented 29.9 percent reduction in maternal mortality between 2000 and 2020, suggests that policy choices—not just resources alone—determine whether pregnant women survive childbirth.
Table of Contents
- How Do Maternal Mortality Rates Actually Compare Between the Two Countries?
- Racial and Ethnic Disparities Distort the Aggregate U.S. Figure
- Uruguay’s Dramatic Progress and the Role of Reproductive Healthcare Access
- What These Maternal Mortality Rates Mean for Public Health Policy
- Age-Related Disparities and the Overlooked Vulnerability of Older Mothers
- International Context and the Stalled Progress of U.S. Maternal Mortality
- The Path Forward for Reducing Maternal Mortality in the United States
- Conclusion
How Do Maternal Mortality Rates Actually Compare Between the Two Countries?
When examining the raw numbers, the comparison is stark: 17.9 per 100,000 in the U.S. (2024) versus 18.6 per 100,000 in Uruguay (2020). The previous year’s U.S. data from 2023 showed 18.6 deaths per 100,000—exactly matching Uruguay’s rate. This numerical parity is not coincidental but reflects the reality that both countries face substantial maternal mortality challenges, though for different reasons and affecting different populations. The timing of the data matters here. The U.S. figure is current as of early 2026, while Uruguay’s data is from 2020, making a direct head-to-head comparison technically imprecise. However, the World Bank data showing Uruguay’s trajectory suggests the gap has not widened significantly in the interim, if at all.
Both countries have seen relatively flat or slightly improving trends in recent years—the U.S. improved from 18.6 in 2023 to 17.9 in 2024, while Uruguay stabilized around 18.6 after years of earlier progress. Neither country should be satisfied with these results given the availability of modern obstetric care and medical technology. A critical limitation of this comparison is that the U.S. maternal mortality rate is measured more comprehensively than many international datasets. The U.S. CDC definition includes pregnancy-related deaths up to one year after the end of pregnancy, capturing deaths from complications like blood clots and infection that occur weeks after delivery. Some international comparisons use narrower definitions, which may artificially lower reported rates in other countries. This methodological difference doesn’t eliminate the validity of the comparison but underscores that Uruguay’s performance is even more noteworthy than the raw numbers suggest.
Racial and Ethnic Disparities Distort the Aggregate U.S. Figure
The U.S. maternal mortality statistic of 17.9 per 100,000 masks profound racial disparities that reveal the country’s true maternal health crisis. Black women experience a maternal mortality rate of 44.8 per 100,000—more than three times higher than the rate for White women, which stands at 14.2 per 100,000. This disparity is not a marginal difference; it represents a structural failure in healthcare access, provider bias, and social determinants that disproportionately harm Black mothers. A Black woman is significantly more likely to die from pregnancy and childbirth complications than her White counterpart, and this gap has persisted despite overall improvements in U.S. maternal health metrics. These disparities are not inevitable or biological.
They reflect systemic inequities in prenatal care quality, treatment during labor, access to specialists, and the responsiveness of healthcare providers to concerning symptoms reported by Black women. Studies have documented that Black women’s pain and health concerns are taken less seriously by medical professionals, leading to delayed treatment and worse outcomes. The fact that uruguay has maintained a lower overall maternal mortality rate without exhibiting the same magnitude of racial health disparities suggests that different policy approaches—including universal healthcare access and earlier intervention for high-risk pregnancies—can mitigate these tragedies. A critical warning emerges from this disparity: national statistics can obscure catastrophic outcomes for specific populations. When policy makers cite the U.S. rate of 17.9 per 100,000 as acceptable or improving, they are ignoring that Black women face a maternal mortality crisis at levels unseen in high-income nations. This is not a demographic quirk but a policy failure stemming from healthcare system design, insurance gaps, and structural racism that compounds medical vulnerability.
Uruguay’s Dramatic Progress and the Role of Reproductive Healthcare Access
Uruguay’s maternal mortality rate has declined 29.9 percent from 2000 to 2020, according to MacroTrends data. This substantial improvement is directly linked to policy choices that expanded access to comprehensive reproductive healthcare, including contraception and safe abortion care. Uruguay legalized abortion in 2012, and this policy shift coincided with increased access to family planning services and improved prenatal and delivery care. The country also invested in universal healthcare access and specialized maternal health programs that prioritized early detection of high-risk pregnancies. The timing of Uruguay’s legal abortion reform is instructive. Before 2012, Uruguayan women faced barriers to reproductive autonomy and lacked options for terminating high-risk pregnancies safely.
The expansion of reproductive choices, combined with stronger healthcare infrastructure, allowed women to plan pregnancies more intentionally and reduced maternal mortality from unsafe abortion attempts and pregnancy complications in women whose health conditions made pregnancy dangerous. This policy approach stands in sharp contrast to U.S. trends, where abortion restrictions have increased following the 2022 Dobbs decision, potentially narrowing options for women with high-risk pregnancies who might otherwise terminate. Uruguay’s achievement offers a data-driven counterargument to the claim that maternal mortality reduction requires only increased healthcare spending. Uruguay spends considerably less per capita on healthcare than the United States, yet has achieved comparable outcomes. The difference lies in universal access to preventive care, family planning, safe abortion services, and transparent healthcare delivery without insurance gaps. For American policymakers focused on reducing maternal mortality, Uruguay’s experience suggests that policy design matters as much as resource allocation.
What These Maternal Mortality Rates Mean for Public Health Policy
The near-identical rates between the U.S. and Uruguay demand serious policy examination because the U.S. has invested far more heavily in healthcare infrastructure and resources. American mothers have access to highly specialized obstetric care, neonatal intensive care units, and advanced medical technology. Yet the country matches the maternal mortality rate of a smaller nation with a less resource-intensive healthcare system. This paradox points to systemic inefficiency, gaps in universal access, and racial disparities that technology and spending alone cannot address. One practical consequence of these comparable rates is that the U.S.
healthcare system is failing to convert its investment advantage into better outcomes for a critical population. Resources are concentrated in well-served hospitals and regions while maternal health gaps persist in rural areas, low-income urban neighborhoods, and communities of color. The comparison with Uruguay suggests that universal coverage, comprehensive prenatal screening, and planned access to abortion care for high-risk pregnancies may be more effective policy levers than incremental investments in specialized care that only portions of the population can reliably access. For pregnant women and their families, this comparison carries a tradeoff. The U.S. offers access to cutting-edge neonatal technology if a woman has adequate insurance and lives near a well-equipped hospital. Uruguay offers more consistent baseline access to prenatal care and family planning but may lack some specialized services available in the U.S. The question for American policy is whether the nation should continue pursuing a model that excels for some while leaving others with worse outcomes than a resource-constrained peer nation, or whether universal baseline care represents a more ethical and effective approach.
Age-Related Disparities and the Overlooked Vulnerability of Older Mothers
The U.S. maternal mortality data reveals a startling age gradient that often receives less attention than racial disparities but is equally compelling. Women age 40 and older experience a maternal mortality rate of 62.3 per 100,000—nearly four times higher than women ages 25 to 39, whose rate is 16.5 per 100,000. Young women under 25 have the lowest rate at 13.7 per 100,000. This age-related vulnerability reflects biological realities—pregnancy complications including gestational diabetes, hypertension, and placental abnormalities increase with age—but also exposes gaps in healthcare screening and management for older pregnant women. A warning emerges from this pattern: as women delay motherhood into their 30s and 40s due to economic pressures, education, or career timing, the population at risk of maternal death increases.
The U.S. maternal mortality crisis, when examined by age, reveals that older women are catastrophically underserved, with mortality rates approaching those seen in countries with much lower healthcare capacity. This is not an inevitable consequence of biology but suggests that American obstetric practice may inadequately screen for, monitor, or manage the pregnancy complications that typically emerge in older mothers. Uruguay’s comparable success in maternal mortality suggests that better prenatal screening and management of chronic disease during pregnancy could substantially reduce these deaths. The limitation of age-based analysis is that it can mask how age and race intersect. Black women in older age groups likely face even higher maternal mortality than the aggregate 62.3 per 100,000 figure for all women 40 and older, though disaggregated data is not always readily available. This intersection of age and race represents a critical gap in maternal health surveillance and intervention.
International Context and the Stalled Progress of U.S. Maternal Mortality
The United States stands alone among high-income nations in having failed to substantially reduce maternal mortality in recent decades, while many peer countries have achieved rates well below 10 per 100,000. Canada reports 5.0 per 100,000, Germany 4.0 per 100,000, and most Western European nations cluster around 3 to 6 per 100,000. Uruguay’s achievement of near-parity with the U.S. at 18.6 per 100,000 is therefore notable not as success but as a baseline marker. The true question is why the wealthy United States, in aggregate, matches or trails countries with lower healthcare spending and simpler healthcare systems.
The international comparison underscores that the U.S. trajectory is not inevitable. The country has not improved substantially since the early 2000s when maternal mortality rates were comparable to today’s figures. Other nations have steadily reduced their rates, suggesting that evidence-based policy changes—including expanded access to family planning, universal prenatal care, and safe abortion services—drive improvement. The U.S. has, by contrast, moved in the opposite direction in some states, with abortion restrictions in the post-Dobbs era potentially narrowing healthcare options for women with high-risk pregnancies.
The Path Forward for Reducing Maternal Mortality in the United States
If the U.S. is to move beyond parity with Uruguay and toward the performance of leading healthcare nations, policy changes must address the documented drivers of maternal death in America: racial health disparities, gaps in insurance coverage and prenatal care access, and healthcare system fragmentation that leaves some women with inadequate monitoring during pregnancy. The CDC data released in March 2026 provides a recent baseline, but without policy intervention, the trajectory suggests stagnation rather than improvement.
Uruguay’s model, while not directly transferable to the U.S. healthcare system, offers evidence that universal baseline access to prenatal care, family planning, and safe abortion services correlates with lower maternal mortality. American policymakers interested in reducing the 649 maternal deaths that occur annually have a data-driven roadmap, though implementation would require confronting entrenched healthcare system inequities and ideological resistance to reproductive healthcare access. The question facing the nation is whether it will continue matching the outcomes of a smaller Latin American country, or whether it will marshal its resources and political will to match the performance of peer developed nations.
Conclusion
The maternal mortality rates of the United States (17.9 per 100,000 in 2024) and Uruguay (18.6 per 100,000 in 2020) are nearly identical, a fact that should provoke serious examination of American healthcare policy and outcomes. This parity is not a source of pride for the U.S., which possesses vastly greater healthcare resources, but rather a signal of systemic failure to convert investment into universal protection of maternal health. The profound racial disparities in the U.S., with Black women experiencing maternal mortality rates exceeding 44 per 100,000, represent the most urgent policy failure masked by national averages.
Policy changes grounded in evidence from Uruguay and other high-performing nations are available: universal prenatal care, comprehensive family planning access, safe abortion services for high-risk pregnancies, and targeted interventions to eliminate racial health disparities. The 649 maternal deaths occurring annually in the United States represent preventable tragedies. Examining how a resource-constrained nation like Uruguay has achieved comparable outcomes—and how other developed nations have substantially outperformed both countries—reveals that policy choices, not resource limitations, are the determining factor. The path to reducing maternal mortality in America is mapped; the question is whether the nation will follow it.